Torley Helen
CIK 1528185
Transactions on file
150
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-08 | 2026-10-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 200 | $22.1K | +13.7% | open → |
| 2026-10-08 | 2026-10-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 11,900 | $1.31M | +14.2% | open → |
| 2026-10-08 | 2026-10-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,090 | $336.5K | +15.4% | open → |
| 2026-10-08 | 2026-10-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,810 | $520.3K | +16.1% | open → |
| 2026-10-08 | 2026-10-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-10-08 | 2026-10-07 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 200 | $22.7K | +10.5% | open → |
| 2026-10-08 | 2026-10-07 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 900 | $101.5K | +11.4% | open → |
| 2026-10-08 | 2026-10-07 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 10,300 | $1.15M | +12.3% | open → |
| 2026-10-08 | 2026-10-07 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 8,600 | $954.9K | +13.1% | open → |
| 2026-10-08 | 2026-10-07 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-10-08 | 2026-10-06 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,780 | $197.2K | +13.4% | open → |
| 2026-10-08 | 2026-10-06 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,920 | $1.09M | +14.3% | open → |
| 2026-10-08 | 2026-10-06 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,000 | $656.0K | +14.9% | open → |
| 2026-10-08 | 2026-10-06 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,300 | $248.2K | +16.4% | open → |
| 2026-10-08 | 2026-10-06 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-09-14 | 2026-09-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,508 | $484.8K | +16.8% | open → |
| 2026-09-14 | 2026-09-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 15,492 | $1.66M | +17.2% | open → |
| 2026-09-14 | 2026-09-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-09-14 | 2026-09-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,412 | $582.2K | +16.8% | open → |
| 2026-09-14 | 2026-09-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 14,588 | $1.56M | +17.4% | open → |
| 2026-09-14 | 2026-09-10 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-09-14 | 2026-09-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 100 | $10.9K | +15.6% | open → |
| 2026-09-14 | 2026-09-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,596 | $711.2K | +16.5% | open → |
| 2026-09-14 | 2026-09-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 13,304 | $1.43M | +17.2% | open → |
| 2026-09-14 | 2026-09-09 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-08-20 | 2026-08-19 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,200 | $344.8K | +16.6% | open → |
| 2026-08-20 | 2026-08-19 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,600 | $1.03M | +17.2% | open → |
| 2026-08-20 | 2026-08-19 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 7,200 | $765.8K | +18.1% | open → |
| 2026-08-20 | 2026-08-19 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-08-20 | 2026-08-18 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,400 | $985.8K | +19.8% | open → |
| 2026-08-20 | 2026-08-18 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,897 | $509.8K | +20.7% | open → |
| 2026-08-20 | 2026-08-18 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,703 | $587.9K | +21.9% | open → |
| 2026-08-20 | 2026-08-18 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 7,500 | $776.1K | +21.4% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,000 | $923.0K | +22.5% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,100 | $213.7K | +23.4% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 500 | $50.2K | +25.1% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 900 | $89.1K | +27.0% | open → |
| 2026-08-20 | 2026-08-17 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $368.2K | +582.4% | open → |
| 2026-07-09 | 2026-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,035 | $83.0K | +56.7% | open → |
| 2026-07-09 | 2026-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 888 | $70.4K | +58.5% | open → |
| 2026-07-09 | 2026-07-08 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 1,923 | $23.2K | +940.8% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,100 | $425.1K | +80.3% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,000 | $137.5K | +82.8% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,500 | $101.5K | +85.6% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 400 | $26.5K | +89.3% | open → |
| 2026-06-04 | 2026-06-03 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 10,000 | $120.7K | +940.8% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,400 | $226.9K | +88.2% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 16,600 | $1.10M | +89.4% | open → |
| 2026-06-04 | 2026-06-02 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +940.8% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,401 | $369.1K | +83.8% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 12,989 | $875.6K | +86.4% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,610 | $106.9K | +89.2% | open → |
| 2026-06-04 | 2026-06-01 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +940.8% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 600 | $42.5K | +77.4% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,950 | $275.7K | +80.0% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,350 | $230.7K | +82.4% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,100 | $143.0K | +84.5% | open → |
| 2026-05-13 | 2026-05-13 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 10,000 | $120.7K | +940.8% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 2,800 | $204.7K | +71.8% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 5,900 | $425.7K | +74.1% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,802 | $699.6K | +76.0% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 1,398 | $98.3K | +78.7% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 100 | $6.8K | +85.2% | open → |
| 2026-05-13 | 2026-05-12 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +940.8% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 6,700 | $444.4K | +89.4% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 3,575 | $234.0K | +91.9% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 9,725 | $628.5K | +94.4% | open → |
| 2026-05-13 | 2026-05-11 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $241.4K | +940.8% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 38,668 | $2.25M | +115.5% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 71,810 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-15 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 7,098 | $413.7K | +115.5% | open → |
| 2025-02-18 | 2025-02-15 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 13,092 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 9,087 | $529.7K | +115.5% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 16,875 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 11,313 | $659.4K | +115.5% | open → |
| 2025-02-18 | 2025-02-16 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 21,009 | $0.00 | — | open → |
| 2025-02-24 | 2025-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 22,436 | $0.00 | — | open → |
| 2025-02-24 | 2025-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 12,081 | $697.7K | +117.5% | open → |
| 2025-06-24 | 2025-06-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 20,000 | $1.05M | +139.0% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 4,489 | $238.4K | +136.5% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1449.1% | open → |
| 2025-06-24 | 2025-06-24 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 15,511 | $836.2K | +133.0% | open → |
| 2025-06-24 | 2025-06-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1449.1% | open → |
| 2025-06-24 | 2025-06-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Sale | 20,000 | $1.06M | +137.2% | open → |
| 2025-06-24 | 2025-06-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1449.1% | open → |
| 2026-02-24 | 2026-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 12,104 | $855.0K | +77.8% | open → |
| 2026-02-24 | 2026-02-23 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 22,436 | $0.00 | — | open → |
| 2026-02-24 | 2026-02-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Tax | 9,040 | $641.7K | +77.0% | open → |
| 2026-02-24 | 2026-02-20 | HALO HALOZYME THERAPEUTICS, INC. | OfficerDirector PRESIDENT AND CEO | Exer. | 16,757 | $0.00 | — | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 724 | $51.9K | +75.3% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,707 | $191.1K | +78.0% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,334 | $163.0K | +79.9% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 14,235 | $974.7K | +83.5% | open → |
| 2025-10-03 | 2025-10-03 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Exer. | 20,000 | $162.2K | +1449.1% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 100 | $7.5K | +68.3% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 700 | $51.3K | +71.5% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 2,400 | $173.0K | +74.3% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 10,200 | $727.0K | +76.3% | open → |
| 2025-10-03 | 2025-10-02 | HALO HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sale | 6,600 | $465.4K | +78.2% | open → |
